It has come to our notice that certain fraudulent individuals or entities are misusing our Company’s name and TCI’s registered trademarks by promoting and offering regulated and hazardous chemical substances through online platforms like YouTube. We hereby categorically clarify that TCI has no association or connection whatsoever with the products being displayed or sold in the videos. These products have been falsely represented as being associated with TCI, and the unauthorized use of our trademark and brand name is both illegal and misleading. TCI Chemicals markets and sells its products exclusively through its official website and authorized distributors. If you become aware of any such fraudulent activity or require clarification, you may reach out to us at: Sales-IN@TCIchemicals.com. Click Here to View the Caution Notice.
Product Document Searching Made Easy by 2D Code! | [Product Highlights] Endogenous Biotin-Blocking Reagent...Maximum quantity allowed is 999
Non-Canonical Amino Acid Which Rapidly Reacts with Maleimide to Allow Site-Specific Modifications into Antibodies
N6-[(Spiro[2.4]hept-4,6-dien-1-ylmethoxy)carbonyl]-L-lysine (1) is useful for the preparation of site-specifically modified antibody-drug conjugates (ADCs).1) The spiroheptadiene (SCp) moiety of 1, introduced into a specific site of the protein by genetic code expansion, selectively reacts with maleimide moiety at a rate of 1.8-5.4 M-1 s-1 via the Diels-Alder reaction.2) ADCs generated by reacting 1-incorporated antibodies with drug-conjugated maleimides exhibit better stability and efficacy than cysteine-maleimide conjugates both in mouse serum and in vivo.
Related Products
- H1840
- N6-[(Spiro[2.4]hept-4,6-dien-1-ylmethoxy)carbonyl]-L-lysine
- T4126
- N-(4E)-TCO-L-lysine
- A3550
- L-Azidohomoalanine
Related Product Category Pages
References
- 1) Click chemistry in the synthesis of antibody-drug conjugates
- 2) A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with Maleimide